Renal artery stenosis in heart failure

Captopril, an oral angiotensin-converting enzyme inhibitor, has proven to be effective in the management of congestive heart failure (CHF). 1 Several trials have documented short- and long-term hemodynamic and clinical improvement with captopril therapy, including increased exercise tolerance. 2,3 H...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 62; no. 17; pp. 1307 - 1308
Main Authors Meissner, Marc D., Wilson, Audrey R., Jessup, Mariell
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.12.1988
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Captopril, an oral angiotensin-converting enzyme inhibitor, has proven to be effective in the management of congestive heart failure (CHF). 1 Several trials have documented short- and long-term hemodynamic and clinical improvement with captopril therapy, including increased exercise tolerance. 2,3 However, captopril may fail to improve or be detrimental to renal function 4 in some patients, particularly if accompanied by marked decreases in systemic pressures. Recent reports have described captopril-induced renal insufficiency in patients with bilateral renal artery stenosis or unilateral stenosis in a solitary kidney 5 and in renal transplant recipients with hypertension. 6 Herein we describe certain findings in 6 of 89 patients with significant CHF seen in a 10-month period in whom a diagnosis of significant renal artery stenosis was made.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9149
1879-1913
DOI:10.1016/0002-9149(88)90283-4